RhoA-mediated signaling in notch-induced senescence-like growth arrest and endothelial barrier dysfunction

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 31, Issue 4, 2011, Pages 876-882

  Venkatesh, Deepak ^a   Fredette, Natalie ^a   Rostama, Bahman ^a   Tang, Yuefeng ^a   Vary, Calvin P H ^a   Liaw, Lucy ^a   Urs, Sumithra ^a  

^a Maine Medical Center Research Institute   (United States)

Author keywords

barrier function; endothelial function; endothelial senescence; Notch; Rho; vascular biology

Indexed keywords

BETA CATENIN; F ACTIN; MYOSIN; MYOSIN LIGHT CHAIN; NOTCH RECEPTOR; PROTEIN P21; PROTEIN P53; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; VASCULAR ENDOTHELIAL CADHERIN;

ARTICLE; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CELL SHAPE; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MORPHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SPROUTING;

ACTINS; ADHERENS JUNCTIONS; ANIMALS; ANTIGENS, CD; BETA CATENIN; CADHERINS; CELL AGING; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MYOSIN LIGHT CHAINS; NEOVASCULARIZATION, PHYSIOLOGIC; PERMEABILITY; PHENOTYPE; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; RECEPTOR, NOTCH1; RECEPTORS, NOTCH; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79953749497     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.110.221945     Document Type: Article

References (34)

1. Hofmann JJ, Iruela-Arispe ML. Notch signaling in blood vessels: who is talking to whom about what? Circ Res. 2007;100:1556-1568. (Pubitemid 46897259)
2. Lindner V, Booth C, Prudovsky I, Small D, Maciag T, Liaw L. Members of the Jagged/Notch gene families are expressed in injured arteries and regulate cell phenotype via alterations in cell matrix and cell-cell interaction. Am J Pathol. 2001;159:875-883. (Pubitemid 32847178)
3. Limbourg A, Ploom M, Elligsen D, Sorensen I, Ziegelhoeffer T, Gossler A, Drexler H, Limbourg FP. Notch ligand Delta-like 1 is essential for postnatal arteriogenesis. Circ Res. 2007;100:363-371.
4. Vasile E, Tomita Y, Brown LF, Kocher O, Dvorak HF. Differential expression of thymosinβ-10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis. FASEB J. 2001;15:458-466. (Pubitemid 32141437)
5. Chau BN, Wang JY. Coordinated regulation of life and death by RB. Nat Rev Cancer. 2003;3:130-138. (Pubitemid 37328880)
6. Li T, Santockyte R, Shen RF, Tekle E, Wang G, Yang DC, Chock PB. Expression of SUMO-2/3 induced senescence through p53-and pRBmediated pathways. J Biol Chem. 2006;281:36221-36227. (Pubitemid 46041356)
7. Corada M, Liao F, Lindgren M, Lampugnani MG, Breviario F, Frank R, Muller WA, Hicklin DJ, Bohlen P, Dejana E. Monoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endothelial permeability. Blood. 2001;97:1679-1684. (Pubitemid 32217233)
8. Guo M, Wu MH, Granger HJ, Yuan SY. Transference of recombinant VE-cadherin cytoplasmic domain alters endothelial junctional integrity and porcine microvascular permeability. J Physiol. 2004;554:78-88. (Pubitemid 38081444)
9. Breslin JW, Yuan SY. Involvement of RhoA and Rho kinase in neutrophil-stimulated endothelial hyperpermeability. Am J Physiol Heart Circ Physiol. 2004;286:H1057-H1062. (Pubitemid 38248621)
10. van Nieuw Amerongen GP, van Delft S, Vermeer MA, Collard JG, van Hinsbergh VW. Activation of RhoA by thrombin in endothelial hyperpermeability: role of Rho kinase and protein tyrosine kinases. Circ Res. 2000;87:335-340. (Pubitemid 30655976)
11. Tang Y, Urs S, Liaw L. Hairy-related transcription factors inhibit Notchinduced smooth muscleβ-actin expression by interfering with Notch intracellular domain/CBF-1 complex interaction with the CBF-1-binding site. Circ Res. 2008;102:661-668. (Pubitemid 351457858)
12. Venkatesh DA, Park KS, Harrington A, Miceli-Libby L, Yoon JK, Liaw L. Cardiovascular and hematopoietic defects associated with Notch1 activation in embryonic Tie2-expressing populations. Circ Res. 2008;103:423-431.
13. Harhaj NS, Felinski EA, Wolpert EB, Sundstrom JM, Gardner TW, Antonetti DA. VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability. Invest Ophthalmol Vis Sci. 2006;47:5106-5115. (Pubitemid 46586418)
14. Kawkitinarong K, Linz-McGillem L, Birukov KG, Garcia JG. Differential regulation of human lung epithelial and endothelial barrier function by thrombin. Am J Respir Cell Mol Biol. 2004;31:517-527. (Pubitemid 39463400)
15. Nakatsu MN, Davis J, Hughes CC. Optimized fibrin gel bead assay for the study of angiogenesis. J Vis Exp. 2007:186.
16. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell. 2005;120:513-522. (Pubitemid 40269765)
17. Thaler S, Hahnel PS, Schad A, Dammann R, Schuler M. RASSF1A mediates p21Cip1/Waf1-dependent cell cycle arrest and senescence through modulation of the Raf-MEK-ERK pathway and inhibition of Akt. Cancer Res. 2009;69:1748-1757.
18. Zhang Y, Herbert BS, Rajashekhar G, Ingram DA, Yoder MC, Clauss M, Rehman J. Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor-β via the p38 mitogenactivated protein kinase pathway. FASEB J. 2009;23:1358-1365.
19. Gil J, Peters G. Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol. 2006;7:667-677. (Pubitemid 44268212)
20. Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D, Barrett JC. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci USA. 1996;93:13742-13747. (Pubitemid 26424190)
21. Tankersley CG, Shank JA, Flanders SE, Soutiere SE, Rabold R, Mitzner W, Wagner EM. Changes in lung permeability and lung mechanics accompany homeostatic instability in senescent mice. J Appl Physiol. 2003;95:1681-1687. (Pubitemid 37169316)
22. van Nieuw Amerongen GP, Beckers CM, Achekar ID, Zeeman S, Musters RJ, van Hinsbergh VW. Involvement of Rho kinase in endothelial barrier maintenance. Arterioscler Thromb Vasc Biol. 2007;27:2332-2339. (Pubitemid 350203947)
23. Wojciak-Stothard B, Ridley AJ. Rho GTPases and the regulation of endothelial permeability. Vascul Pharmacol. 2002;39:187-199. (Pubitemid 37492962)
24. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science. 1999;284:770-776. (Pubitemid 29291335)
25. Noseda M, McLean G, Niessen K, Chang L, Pollet I, Montpetit R, Shahidi R, Dorovini-Zis K, Li L, Beckstead B, Durand RE, Hoodless PA, Karsan A. Notch activation results in phenotypic and functional changes consistent with endothelial-to-mesenchymal transformation. Circ Res. 2004;94:910-917. (Pubitemid 38490068)
26. Kolev V, Kacer D, Trifonova R, Small D, Duarte M, Soldi R, Graziani I, Sideleva O, Larman B, Maciag T, Prudovsky I. The intracellular domain of Notch ligand Delta1 induces cell growth arrest. FEBS Lett. 2005;579: 5798-5802. (Pubitemid 41455666)
27. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature. 1993;366:704-707. (Pubitemid 24036021)
28. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 1997;88:593-602. (Pubitemid 27152402)
29. Sriuranpong V, Borges MW, Ravi RK, Arnold DR, Nelkin BD, Baylin SB, Ball DW. Notch signaling induces cell cycle arrest in small cell lung cancer cells. Cancer Res. 2001;61:3200-3205. (Pubitemid 32691976)
30. Miyauchi H, Minamino T, Tateno K, Kunieda T, Toko H, Komuro I. Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway. EMBO J. 2004;23:212-220. (Pubitemid 38165761)
31. Narita M, Nunez S, Heard E, Narita M, Lin AW, Hearn SA, Spector DL, Hannon GJ, Lowe SW. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell. 2003;113:703-716. (Pubitemid 36724935)
32. Stein GH, Drullinger LF, Soulard A, Dulic V. Differential roles for cyclindependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol Cell Biol. 1999;19:2109-2117. (Pubitemid 29098269)
33. Bazzoni G, Dejana E. Pores in the sieve and channels in the wall: control of paracellular permeability by junctional proteins in endothelial cells. Microcirculation. 2001;8:143-152. (Pubitemid 33605130)
34. Ai S, Kuzuya M, Koike T, Asai T, Kanda S, Maeda K, Shibata T, Iguchi A. Rho-Rho kinase is involved in smooth muscle cell migration through myosin light chain phosphorylation-dependent and independent pathways. Atherosclerosis. 2001;155:321-327. (Pubitemid 32209302)